The King Abdullah International Medical Research Centre, in collaboration with the Jenner Institute has started a Phase I clinical trial in Saudi Arabia for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The trial will be the first Phase I clinical trial ever to be conducted in the country and will provide valuable clinical data. MERS-CoV causes an emerging zoonotic viral respiratory disease that was first described in 2012 and is now endemic in Saudi Arabia.
¬† The first recipient of the Navin Venkatraman DPhil Scholarship was announced at the NDM Prize Ceremony at the Oxford University Museum of Natural History¬† The Scholarship was awarded to Mehreen Datoo, a Clinical Resarch Fellow and DPhil student at The Jenner Institute, to support her studies on ...
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1. Mol Ther Methods Clin Dev, 14, pp. 148-160. Article
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technol Assess, 23 (38), pp. 1-92. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.